All Activity

Sustain the nice do the job, When i understand several threads within this web page in addition to I'm sure that a world-wide-web blog site is usually authentic useful possesses bought communities connected with excellent facts. abonnement iptv hd

In crossy road, you steer the character through challenges like busy streets, flowing rivers, and oncoming vehicles, striving to achieve the highest score possible.

Thanks for the nice blog. It was very useful for me. I'm happy I found this blog. Thank you for sharing with us,I too always learn something new from your post. zarif wijdan lawn

I appreciate the thoughtfulness you put into your content. https://www.edmontonfurnacecare.com/

Connecticut lawmakers are among the latest in the U.S. to take up legislation to allow medical marijuana use by certain qualifying patients at health facilities such as hospitals, nursing homes and hospices. Members of the legislature’s Joint Committee on Public Health convened to discuss the cannabis bill at a hearing on Monday, taking testimony from state agencies, medical institutions and more as they consider implementing a policy known as “Ryan’s law,” named after a young California medical cannabis patient who passed away. Under the proposal, terminally ill patients could access cannabis products that could not be smoked or vaporized at health facilities such as hospitals. That would not extend to patients receiving emergency care, however. The bill, HB 5242, also stipulates that health facilities could suspend the medical cannabis allowance if a federal agency such as the Justice Department or Centers for Medicare & Medicaid Services (CMS) initiates an enforcement action or issues guidance specifically prohibiting medical marijuana access on their premises. Erin Gorman Kirk, Connecticut’s Cannabis Ombudsman, advised the joint committee that current policy means “a registered patient facing a terminal prognosis may be forced to abandon their legally authorized regimen the moment they are admitted to a hospital or nursing home.” “Patients who cannot or will not tolerate opioids, or who have found in medical cannabis the only effective relief for their pain, nausea, or anxiety, are left without options simply because of where they receive care,” she said. “HB 5242 corrects this by requiring covered facilities to allow those with a terminal prognosis of one year or less, to use non-smokable cannabis forms including tinctures, edibles, and topicals.” “HB 5242 is important, impactful, and morally necessary. It is a n ethical, commonsense bill that protects vulnerable patients who do not want opioids, who cannot tolerate them, or who have simply found in cannabis the relief and clarity that allows them to die with dignity. Medical cannabis is backed by clinical evidence, endorsed by nurses and policy analysts who work with these patients every day, and modeled on laws that are working right now in states across the country. Connecticut should not be a state that tells a dying patient: your medicine is legal, your doctor approved it, but you cannot have it here.” The Connecticut Hospital Association (CHA), meanwhile, voiced opposition to the proposal, telling lawmakers that the bill “misapprehends several issues about the laws and regulations governing hospitals.” “HB 5242 requires Connecticut hospitals to break the law—a law that [the Department of Public Health, or DPH] itself will need to enforce as part of the [Centers for Medicare and Medicaid Services, or CMS] oversight system and the Department of Consumer Protection (DCP) would need to enforce as part of its role overseeing controlled substances laws,” it said. The Connecticut Association of Health Care Facilities and Connecticut Center for Assisted Living (CAHCF/CCAL) also submitted testimony in opposition to the reform, advising that “compliance would place providers in a very difficult and untenable situation of trying to navigate conflicting federal and state laws.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Lawmakers in multiple states are advancing similar bills meant to provide patients with access to medical marijuana in health care facilities, with legislators across the U.S. making the case this week for a policy change they say is necessary to ensure patients have a full range of treatment options at their disposal. Last week alone, Ryan’s law proposals saw action in at least four states: Colorado, Hawaii, Virginia and Washington State. Photo courtesy of Philip Steffan. The post Connecticut Lawmakers Take Up Bill To Allow Medical Marijuana Access In Hospitals appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Hawaii senators have advanced a bill to create a psychedelics task force responsible for studying and making policy recommendations on providing access to breakthrough therapies such as psilocybin and MDMA. Members of the Senate Health and Human Services Committee approved the legislation from Sen. Chris Lee (D), with amendments, in a 5-0 vote on Wednesday. The measure would create a Mental Health Emerging Therapies Task Force that’d be tasked with spending two years reviewing the current scientific literature, supporting additional clinical research and “developing policy recommendations for safe, ethical, and culturally-informed implementation” of a psychedelics therapy program. “The legislature finds that addressing the mental health crisis affecting the residents of the State, particularly among veterans, first responders, and trauma survivors, is urgent,” the bill, SB 3199, states. “Suicide continues to be a leading cause of preventable death, and the State must explore all safe and effective treatment options supported by scientific evidence.” Noting that the federal Food and Drug Administration (FDA) has already designated psilocybin and MDMA as breakthrough therapies in the treatment of serious mental health conditions, which could lend to future rescheduling under the Controlled Substances Act (CSA), the Hawaii legislation says the state “must proactively prepare public health, clinical, and research systems for safe and equitable implementation.” Members of the task force would have to include representatives of the state Department of Health (DOH), the attorney general’s office, the Office of Wellness and Resilience (OWR), the University of Hawaii’s medical school and more. As drafted, DOH would have overseen the task force, but that was amended in committee to make it the responsibility of “an entity with demonstrated expertise in primary scientific research and pharmaceutical or medical education.” “Administrative placement of the task force within an entity with demonstrated expertise in primary scientific research and pharmaceutical or medical education shall not be construed to transfer, delegate, diminish, expand, or otherwise modify any regulatory, enforcement, licensing, scheduling, or rulemaking authority vested in the Department of Health, Board of Pharmacy, or any other state agency,” the bill as revised says. “All statutory authority relating to controlled substances, professional licensure, and public health regulation shall remain with the appropriate executive branch agencies as provided by law.” The proposal has been referred to the House Ways & Means Committee for further discussion. It appears that the bill would build upon prior work conducted by a separate psychedelics task force that convened for the first time in 2023, with a similar goal of exploring pathways for therapeutic access into FDA-approved breakthrough drugs like psilocybin. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, Hawaii senators recently approved a bill to legalize low-dose and low-potency marijuana, even as their counterparts in the House of Representatives say cannabis prohibition will not be ended in the state this year. The Health and Human Services Committee on Wednesday also approved a bill to allow patients to immediately access medical cannabis once their registrations are submitted, instead of having to wait until their cards are delivered as is the case under current law. A separate marijuana legalization bill that contained provisions making the reform contingent on changes to federal law or the state Constitution, SB 2421, was deferred for action. Both Senate and House panels additionally deferred action on a measure to allow for the sale of certain hemp-derived cannabinoid products. The Senate committee action comes after key House lawmakers signaled that cannabis legalization proposals would not be advancing in the 2026 session, citing a lack of sufficient support in their chamber. Image courtesy of CostaPPR. The post Hawaii Senators Approve Bill To Create Psychedelics Task Force To Study Pathways For Access To Psilocybin, MDMA And More appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Florida campaign seeking to put marijuana legalization on the ballot is facing another complication as it continues to litigate the status of its 2026 signature drive. Under a new election law, the hundreds of thousands of signatures activists already collected for this year will not be carried over into the 2028 cycle. Gov. Ron DeSantis (R) signed a bill into law last year that makes several fundamental changes to the ballot process in a way that advocates say significantly undermines their ability to put citizen initiatives before voters, including a policy to reset the signature clock for each election cycle. Accordingly, the state Division of Elections page for the Smart & Safe Florida cannabis measure now shows 0 verified signatures for the 2028 ballot, erasing the nearly 800,000 signatures the campaign gathered to put legalization on the ballot this November. Officials said activists failed to meet the signature threshold for this upcoming election, but that matter is still being separately challenged in the state Supreme Court. “The new law means all signatures expire for the new cycle,” a Smart & Safe Florida spokesperson told Marijuana Moment on Monday, calling it “one more way they screwed over voters.” Other changes to the state election law includes new policies creating stricter formatting rules for ballot petitions, registration requirements for signature collectors, limitations on the number of ballot issues per campaign committee and more. The cannabis campaign hasn’t given up its bid for the 2026 ballot just yet, however. And so depending on the outcome of the pending litigation, it could theoretically avoid navigating the updated election rules for 2028. Smart & Safe Florida recently submitted an appeal to the state Supreme Court concerning the invalidation of about 71,000 signatures for its 2026 petition, for example. While the court agreed to close a separate case involving a legal review into the ballot measure from Smart & Safe Florida, it’s now been handed another case challenging the earlier mass signature invalidation. Back in December, advocates filed a lawsuit in the Leon County circuit court, claiming Secretary of State Cord Byrd (R) unlawfully directed county election officials to invalidate about 42,000 signatures from so-called “inactive” voters and roughly 29,000 signatures collected by out-of-state petitioners. That lawsuit came after another court upheld a previous decision to strike about 200,000 signatures that the state said were invalid because the petitions didn’t include the full text of the proposed initiative. The campaign contested the legal interpretation, but it declined to appeal the decision based on their confidence they’d collected enough signatures to make up the difference. Smart & Safe Florida has generally disputed the secretary of state’s signature count, asserting the campaign submitted over 1.4 million petitions—hundreds of thousands more than the 880,062 valid signatures required to go before voters. In a recent filing with the Supreme Court, Attorney General James Uthmeier (R) said his office was withdrawing its earlier request for a legal review in the constitutionality of the proposed cannabis initiative because the state claimed the campaign submitted an insufficient number of signed petitions. The last count, according to the secretary of state’s office, was 783,592 validated signatures. In its reply brief, Smart & Safe Florida said the secretary of state’s office made a determination that the campaign didn’t satisfy requirements for ballot placement based on a “conclusion that the Sponsor failed to meet the requisite signature threshold in light of the invalidations that the Sponsor is contesting.” Ahead of the signature turn-in, Florida’s attorney general and several business and anti-marijuana groups urged the state Supreme Court to block the cannabis initiative, calling it “fatally flawed” and unconstitutional. The Florida Chamber of Commerce, Florida Legal Foundation and Judge Frank Shepherd filed a separate joint brief stating that the parties remain “especially vigilant about the abuse of the citizen initiative process by out-of-state interests that think of Florida as just another market and the citizen initiative process as just another means of exploiting that market.” The Florida Chamber of Commerce has consistently opposed attempts to move forward with adult-use legalization, even as its own polling has shown majority support for the reform. The campaign fought several legal battles this cycle to ensure that its initiative is able to qualify for ballot placement. Last month, the state attorney general’s office opened dozens of criminal investigations and submitted subpoenas requesting records from Smart & Safe Florida and its contractors and subcontractors over alleged fraud related to the petitioning effort. Activists said in November that they’d collected more than one million signatures to put the cannabis measure on the ballot, but it’s also challenged officials at the state Supreme Court level over delays the certification process, arguing that the review of the ballot content and summary should have moving forward months ago when it reached an initial signature threshold. The state then agreed to move forward with the processing. The governor campaigned heavily against an earlier version of the legalization proposal, which received a majority of voters in 2024 but not enough to meet the 60 percent threshold required to pass a constitutional amendment. Former Attorney General Ashley Moody (R) unsuccessfully contested the prior initiative in the courts. Last March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to DeSantis. The money was used to fight against a citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. The lawmakers’ letter followed allegations that a $10 million donation from a state legal settlement was improperly made to the Hope Florida Foundation, which later sent the money to two political nonprofits, which in turn sent $8.5 million to a campaign opposing Amendment 3. The governor said last February that the newest marijuana legalization measure is in “big time trouble” with the state Supreme Court, predicting it would be blocked from going before voters this year. “There’s a lot of different perspectives on on marijuana,” DeSantis said. “It should not be in our Constitution. If you feel strongly about it, you have elections for the legislature. Go back candidates that you believe will be able to deliver what your vision is on that.” “But when you put these things in the Constitution—and I think, I mean, the way they wrote, there’s all kinds of things going on in here. I think it’s going to have big time trouble getting through the Florida Supreme Court,” he said. The latest initiative was filed with the secretary of state’s office just months after the initial version failed during the November 2024 election—despite an endorsement from President Donald Trump. Smart & Safe Florida expressed optimism that the revised version would succeed in 2026. The campaign—which in the last election cycle received tens of millions of dollars from cannabis industry stakeholders, principally the multi-state operator Trulieve—incorporated certain changes into the new version that seem responsive to criticism opponents raised during the 2024 push. For example, it now specifically states that the “smoking and vaping of marijuana in any public place is prohibited.”Another section asserts that the legislature would need to approve rules dealing with the “regulation of the time, place, and manner of the public consumption of marijuana.” In 2023, the governor accurately predicted that the 2024 cannabis measure from the campaign would survive a legal challenge from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome. While there’s uncertainty around how the state’s highest court will navigate the measure, a poll released last February showed overwhelming bipartisan voter support for the reform—with 67 percent of Florida voters backing legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background, a recent poll from a Trump-affiliated research firm found that nearly 9 in 10 Florida voters say they should have the right to decide to legalize marijuana in the state. Meanwhile, earlier this month, Florida senators approved an amended bill to increase the amount of medical marijuana a registered patient can buy and slash the fee for medical cannabis identification cards for military veterans. The vote came after the Senate Regulated Industries Committee passed separate legislation to ban smoking or vaping marijuana in public places. Rep. Alex Andrade (R) is sponsoring a similar bill to ban public cannabis smoking in the House. Here’s an overview of other pending Florida marijuana bills: A House lawmaker is sponsoring a bill to legalize recreational marijuana that also aims to break up what he calls “monopolies” in the state’s current medical cannabis program by revising the business licensing structure. Another representative’s bill would protect the parental rights of medical cannabis patients, preventing them from losing custody of their children for using their medicine in accordance with state law. A senator is sponsoring a bill to legalize home cultivation of marijuana for registered medical cannabis patients in the state. Photo courtesy of Chris Wallis // Side Pocket Images. The post Florida Officials Reset Marijuana Campaign’s Signatures To Zero For Legalization Ballot Initiative As Legal Challenges Persist appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Mehmet Oz, the head of the Centers for Medicare & Medicaid Services (CMS), says “there are going to be consequences” as more Americans choose marijuana over alcohol—including problems caused by “high-dose hemp and CBD.” As the Trump administration works to finalize a cannabis rescheduling proposal and prepares to roll out a CBD coverage plan through Medicare under Oz’s agency, the health official curiously raised concerns about non-intoxicating cannabidiol and hemp products overall. During an interview with Katie Miller—the wife of top Trump advisor Stephen Miller—Oz was asked whether shifts in consumer preferences away from alcohol and toward cannabis pose any risks. And the CMS administrator answered affirmatively. “Anything that’s strong enough to help you is strong enough to hurt you. So yes, there are going to be consequences,” he said. “We already know that some of the high-dose hemp and CBD is a problem.” The comments are especially notable given that Oz is leading an initiative tied to the marijuana rescheduling executive order President Donald Trump issued in December that’s meant to incorporate CBD coverage under federal health care programs. The health official has made multiple statements over recent years supporting the therapeutic use of marijuana and its constituents. As part of Trump’s executive order, the attorney general was separately directed to expeditiously complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). As for hemp and CBD, those were federally legalized under the 2018 Farm Bill the president signed into law during his first term, though industry advocates have warned about cannabinoid products’ continued availability under more recent legislation Trump approved to recriminalize hemp THC. Trump himself shared a video on Truth Social last year touting the benefits of CBD, particular for seniors. Meanwhile, an industry stakeholder working with the administration on its CBD Medicare initiative said recently that CMS already finalized a rule to provide federal health insurance coverage for the cannabinoid, but the White House has not confirmed the status of the rulemaking. Oz, for his part, spoke about the initiative at the signing ceremony for the underlying executive order, crediting Trump and U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for “pushing for change” and “relentlessly” pursuing an agenda rooted in a “deep passion for research.” The plan has been to create a pilot program enabling eligible patients to access hemp-derived cannabidiol that’d be covered under federal health insurance plans, projected to launch by April, according to Oz. At the signing ceremony in December, Oz also gave kudos to Howard Kessler, founder of The Commonwealth Project, which produced the video about the benefits of cannabidiol for seniors that Trump shared. While CMS implemented an earlier final rule last April specifically stipulating that marijuana, as well as CBD that can be derived from federally legal hemp, are ineligible for coverage under its Medicare Advantage program and other services, the agency is now revising that policy. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — CMS had already announced certain changes as part of a rulemaking process that was unveiled late last year, affecting “marketing and communications, drug coverage, enrollment processes, special needs plans, and other programmatic areas” for insurance programs it oversees. One of those changes dealt with cannabidiol coverage. In recent years, Oz has encouraged audiences to be open to therapeutic cannabis and advocated for sweeping policy changes around the drug. “We ought to completely change our policy on marijuana. It absolutely works,” he said in a 2020 interview, calling cannabis “one of the most underused tools in America.” In 2024, he wrote in a syndicated health column that there’s evidence cannabinoids can curb seizures, alleviate nausea associated with cancer treatment and potentially help manage pain—especially in older people. Oz also said in 2020 that he believes that, particularly for seniors, marijuana for pain represents a “safer solution than, for example, narcotics in many cases.” The post Dr. Oz Warns Of ‘Consequences’ As People Choose Marijuana Over Alcohol, Citing Concerns About ‘High-Dose Hemp And CBD’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

La mutation des usages vers les écrans portables a imposé une révision complète de la conception des interfaces, et l'ergonomie tactile de https://julius-casino-fr.one/ représente un modèle du genre. L'ensemble de la navigation a été repensé pour s'adapter aux interactions par gestes. Les zones de balayage et les boutons d'action sont idéalement proportionnés pour éviter les erreurs de manipulation, garantissant une utilisation confortable même sur les écrans de taille réduite.

The Maryland House of Delegates has approved a bill to extend a psychedelics task force through the end of 2027 to develop updated recommendations on expanding therapeutic access to the novel drugs and potentially creating a regulatory framework for broader legalization. Meanwhile, a Senate committee advanced a companion measure with a minor amendment. Just days after moving through the House Health Committee, the full chamber passed the legislation from Del. Pam Guzzone in a 110-25 vote on Thursday. On the same day, the Senate Finance Committee approved that chamber’s version of the measure, sponsored by Sen. Brian Feldman (D), but with an amendment to add a representative of a historically black college or university to the task force. The panel had held a hearing on the psychedelics measure days earlier. Both chambers’ proposals are aimed at building upon a current law that created the Maryland Task Force on Responsible Use of Natural Psychedelic Substances. “It’s just to give them one extra year to finish out their work. So it’s just to extend it for one year—to expand it in any way,” Del. Teresa Woorman (D) said on the House floor on Thursday. “We’re not changing their mandate or anything. We’re just giving them one more year to finish out the reporting.” “They gave us a great work up in committee about all the work that they’ve done, and all of their research has been published. They have produced over 200 pages of documents,” she said.”But they could just really use the extra year to just pile up everything. There’s a lot of expertise on the panel, and it would be a shame to not let them finish out their work before we have to wrap up this task force and start over again.” That panel released an initial final report to state lawmakers last year, with recommendations for the phased implementation of a wide range of reforms to provide legal therapeutic access to substances such as psilocybin. Members of the task force have already advised that it was ultimately recommending a “multi-pathway framework for safe, broad, and equitable access to natural psychedelic substances, with an initial focus on psilocybin.” The psychedelics task force was formed following Gov. Wes Moore’s (D) signing of a pair of bills into law in 2024. The 17-person body, overseen by the Maryland Cannabis Administration (MCA), was charged with studying how to ensure “broad, equitable and affordable access to psychedelic substances” in the state. SB 336 and HB 427 would continue that work, maintaining the panel through December 31, 2027. In the interim, the task force would be required to submit an updated report to legislators with additional findings and recommendations by October 31 of this year. Beyond the extended timeline for the task force to study and develop the report, the current law would not change under the legislation. The multi-step regulatory framework that members recommended last year “involves phased implementation of complementary elements from medical/therapeutic use and supervised adult use, to deprioritization, and to commercial sales,” the report said. “This model broadly and inclusively serves the needs of Maryland’s diverse population while enabling unified safety standards, accountability, and viable economic pathways for small businesses.” The first phase of the plan would be to create an advisory board to establish safety parameters, data monitoring, practice guidelines, licensing protections, public education campaigns, training for facilitators, law enforcement and testing facilities, as well as “immediate restorative justice measures,” the report states. Under phase two, the state would implement “deprioritization measures” to mitigate the harms of criminalization, provide for supervised medical and adult-use consumption facilities, allow personal cultivation for “permitted individuals” and promote research processes. Finally, phase three would be contingent on the “demonstrated safety outcomes and provider confidence” based on the prior steps. Should those factors be satisfied, the last phase would lead to a commercial sales program for adults “who maintain an active license to use natural psychedelic substances,” coupled with an evaluation of the state’s “readiness for expanding to additional natural psychedelic substances.” “Safety and oversight measures ensure responsible and gradual expansion of access while maintaining capacity to identify and respond to emerging issues swiftly,” the report said. “This approach plans for long-term learning and improvement: starting small, utilizing built-in evaluation and accountability mechanisms from the outset, gathering real-world data, and committing to an iterative approach to policymaking.” Notably, the task force said it did not support “delaying state action pending future federal [Food and Drug Administration] approval.” “The Task Force recognizes that implementing such a comprehensive framework requires careful sequencing and coordination, with particular attention to scope of practice issues that may significantly affect the viability and safety of different pathways. However, the order of implementation must carefully consider professional regulatory frameworks and safety concerns raised by medical organizations and health care providers. The Task Force’s recommendation for simultaneous implementation of multiple pathways does not mean that all components must activate on the exact same day, but rather that Maryland should avoid the sequential approach seen in other jurisdictions where implementing one pathway causes others to ‘languish,’and/or bolster black and gray markets.” Rather, the task force said, the multi-phase approach to psychedelics reform “establishes foundational systems that support all pathways equally, followed by a coordinated launch of medical, supervised adult use, and deprioritization pathways, with commercial sales following once product safety systems are operational.” Members also said that the model envisioned could be used by other states to develop their own laws that “adapt to their own circumstances and values.”At this point, the task force is only looking at psilocybin, mescaline and DMT. While the legislature empowered members to investigate potential regulations for other psychedelic substances, they decided to take a more conservative approach in their initial work. As originally introduced, the House version of the task force legislation contained more prescriptive requirements to explore and issue recommendations on aspects of psychedelics policy such as “systems to support statewide online sales of natural psychedelic substances with home delivery” and “testing and packaging requirements for products containing natural psychedelic substances with clear and accurate labeling of potency.” That language was ultimately removed, however. The task force legislation advanced about two years after a different law took effect creating a state fund to provide “cost-free” access to psychedelics like psilocybin, MDMA and ketamine for military veterans suffering from PTSD and traumatic brain injury. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, earlier this month, Maryland lawmakers took up a bill to protect the gun rights of medical marijuana patients in the state. Members of the House Judiciary Committee discussed the legislation from Del. Robin Grammer (R), who has sponsored multiple versions of the cannabis and gun rights measure over recent sessions, but they have not yet advanced to enactment. Meanwhile, a Republican congressional lawmaker representing Maryland who has built a reputation as one of the staunchest opponents of marijuana reform on Capitol Hill—and whose record includes ensuring that Washington, D.C. officials are blocked from legalizing recreational cannabis sales—may be at risk of being unseated in November due to redistricting in his state. Photo elements courtesy of carlosemmaskype and Apollo. The post Maryland Lawmakers Approve Bills To Extend Psychedelics Task Force Through 2027 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Getting the “munchies” after using marijuana isn’t just in your head. It’s a real biological phenomenon that could hold important, real-world implications for people suffering from conditions associated with appetite loss, according to a new study that also identified some of the most commonly desired food items while high. Researchers at Washington State University (WSU) and the University of Calgary sought out to investigate the well-known cannabis experience, which is often comically portrayed in media as a hunger-inducing side effect that’s coupled with copious consumption of Doritos and other unhealthful snack foods. While that might be how some people manage the munchies, the appetite stimulation associated with cannabis has the potential to meaningfully help people with serious health conditions, the researchers said in the study, which was recently published in the Proceedings of the National Academy of Sciences (PNAS). The human clinical trial involved 82 volunteers aged 21 to 62. Participants were randomly assigned to vape either 20 or 40 milligrams of cannabis, or a placebo for the control group, and were assessed to determine what kind of factors might impact the appetite effect. The study also involved similar assessments using a rat model. “Cannabis acutely and robustly increases energy intake, food motivation, and reward value, irrespective of food type, satiety, food aversion, and gender/sex.” “There are a lot of different diseases, conditions and disorders associated with wasting syndromes and lack of appetite, and this study really supports the idea that cannabis can be used medicinally to increase appetite in people who have conditions like HIV, AIDS, or who are on chemotherapy,” Carrie Cuttler, a psychology professor at WSU, said in a press release. Interestingly, the study found that people didn’t universally gravitate toward one type of food option over another. Some participants were inclined to eat carbohydrate-heavy foods, others preferred proteins and some fell closer into the stereotype by choosing fatty snack foods. But there were some common, if unexpected, themes. “Beef jerky was one of the No. 1 things intoxicated people gravitated toward, which I don’t understand. Honestly, I would have thought chocolate, chips, Rice Krispies treats—things like that,” Cuttler said, adding that water was among the most desired items. Ryan McLaughlin, a WSU veterinary science professor, said that the “human study found irrespective of body mass index, time of last food consumption, sex or how much cannabis was consumed, human participants who used cannabis during the trial ate significantly more food,.” The rat-based trial similarly demonstrated that cannabis commonly triggered an appetite response in the animals, which pulled levers to obtain food at a much higher rate compared to the control group. “The sober animals are kind of like, ‘I’m full. Why do I care?’ They don’t put in any effort at all. They barely work in any capacity to get access to food,” The University of Calgary’s Matthew Hill said. “But you get them stoned again, and even though they’re now full and they’ve eaten, they go right back as if they’re starving.” “The same thing we saw in the humans we saw in the rats. We kind of thought it would make them want to eat carb-rich foods, but that didn’t seem to be the case. It just seemed to be any food,” he said. The findings reinforce what’s been established in earlier research into the endocannabinoid system. THC stimulates the hypothalamus and “hijacks that entire system,” McLaughlin said. “So even though you’re not necessarily hungry, THC can stimulate cannabinoid receptors in the brain and make you feel hungry.” “That’s what really gives us the opportunity to look at whether this is something brain-mediated or gut-mediated, and this generally shows ‘the munchies’ are mediated by the brain,” he said. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — This is far from the only study to look at the relationship between marijuana and appetite. For example, in 2024, WSU researchers separately published a federally funded study that identified exactly what happens in the brain after using marijuana that causes the munchies. The research, published in Scientific Reports, revealed how cannabis activates a specific cluster of neurons in the hypothalamus region of the brain that stimulates appetite. A 2019 study separately found that sales of commonly munched on products like ice cream, cookies and chips tend to go up after states legalize cannabis. Despite that, a 2022 study determined that adult-use legalization is actually associated with decreased levels of obesity despite the fact that cannabis is well-known appetite stimulator. In 2024, meanwhile, a meta-analysis also found that people who use marijuana are about half as likely to develop type 2 diabetes. The post Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

it's truly wonderful weblog. it's realy educational along with a this type of great work. i really like this particular. สล็อตเว็บตรง

There are a lot of blogs over the Internet. But I can surely say that your blog is amazing in all. It has all the qualities that a perfect blog should have. zarif wijdan lawn

Multiple states advance medical marijuana in hospitals bills; NYC mayor’s cannabis tax projections; Hemp letter to McConnell; AZ cannabis smoke bill Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Department of Justice told the U.S. Supreme Court that the federal law banning marijuana consumers from owning guns should be upheld—even if President Donald Trump’s cannabis rescheduling order is finalized. Rep. James Comer (R-KY) and Kentucky’s agriculture commissioner sent a letter urging Sen. Mitch McConnell (R-KY) to support delaying the federal recriminalization of hemp THC products that he championed before it was signed into law by President Donald Trump. Lawmakers in Colorado, Hawaii, Virginia and Washington State all approved bills last week to allow patients to access medical cannabis in hospitals and other healthcare facilities. The Arizona Senate Judiciary and Elections Committee approved two pieces of legislation to criminalize the “creation of excessive marijuana smoke or odor,” with one that would refer the issue to voters to decide on at the ballot. The Maryland Senate Finance Committee held a hearing on a bill to protect firefighters and rescue workers from being penalized for off-duty use of medical cannabis, with the sponsor saying marijuana provides a “safer, viable alternative” to opioids. New York City Mayor Zohran Mamdani’s (D) budget says the rise in marijuana tax revenue “has not been as rapid as the expansion in store openings” because of competition among suppliers and low prices—but projects that it will increase to $43 million by fiscal year 2030. NORML Deputy Director Paul Armentano argues in a new Marijuana Moment op-ed that The New York Times editorial board made several errors in a piece expressing concerns about cannabis legalization—but was correct to say the U.S. shouldn’t return to “heavy-handed criminal prohibition.” The Rhode Island Cannabis Control Commission has still not settled on the process by which it will award up to 20 new marijuana dispensary licenses to applicants chosen by a lottery as early as May. / FEDERAL Nebraska independent Senate candidate Dan Osborn posted a video of himself criticizing Sen. Pete Ricketts’s (R-NE) opposition to medical cannabis. / STATES The Oklahoma House County and Municipal Government Committee approved a bill to allow counties to enact local medical cannabis taxes. The Nebraska legislature’s Health and Human Services Committee held a hearing on a bill to provide legal protections to doctors who recommend medical cannabis. The West Virginia House Health and Human Resources Committee is considering a bill to allow medical cannabis edibles. New Hampshire senators discussed legislation to change medical cannabis business rules. Ohio regulators issued a recall on cannabis gummies that weren’t properly labeled as containing THC. Missouri regulators launched an initiative to help consumers identify licensed dispensaries and cannabis products. Colorado regulators published an annual marijuana regulatory and enforcement report. California regulators sent updates on various cannabis issues. Minnesota regulators are hosting the first event of a statewide cannabis listening tour on March 13. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Several Oklahoma county district attorneys weighed in on Gov. Kevin Stitt’s (R) proposal to roll back medical cannabis legalization. / INTERNATIONAL Malta Prime Minister Robert Abela said outstanding reports from cannabis regulators will be published soon. / SCIENCE & HEALTH A study found that “adolescent lifetime and recent cannabis use have decreased since the late 1990s.” A case report indicated that “cannabis oil may be a promising adjunct therapeutic option in the treatment of multicentric lymphoma in dogs, aiding in the management of chemotherapy-related adverse effects.” / BUSINESS Green Thumb Industries Inc. increased an existing syndicated credit facility by $50 million, bringing the total facility to $189 million. The Cannabist Company Holdings Inc.’s former CEO was ordered by a Canadian court to pay more than C$7.4 million after he allegedly engaged in a financial workaround to bypass U.S. securities regulations. Michigan retailers sold $226.8 million worth of legal marijuana products in January. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post DOJ defends cannabis user gun ban, even if rescheduling happens (Newsletter: February 23, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A very excellent blog post. I am thankful for your blog post. I have found a lot of approaches after visiting your post. zarif wijdan collection

An fascinating discussion is value comment. I think that it is best to write extra on this matter, it won’t be a taboo topic however generally people are not enough to talk on such topics. To the next. Cheers zarif collection

This is very educational content and written well for a change. It's nice to see that some people still understand how to write a quality post! zarif wijdanexclusive

I appreciated your work very thanks zarif wijdan collection

I think this is an informative post and it is very useful and knowledgeable. therefore, I would like to thank you for the efforts you have made in writing this article. Zarif lawn

I think that thanks for the valuabe information and insights you have so provided here. 성인피씨방넷

That is really nice to hear. thank you for the update and good luck. zarif wijdan

Thanks for the blog loaded with so many information. Stopping by your blog helped me to get what I was looking for. zarif luxury collection

Great article — I value the focus on server-side anti-cheat technology. Robust security improves overall enjoyment for serious players. Real player feedback confirmed the effectiveness. 강남보스턴

Usual visitors here's the easiest way to thank you so much in your effort and hard work, which unfortunately is the reason why I will be touring the location day to day, in need of different, appealing advice. Countless, bless you! iptv premium

About Company - Based in Fairfax, VA, My Move Day is a trusted team of professional movers providing expert, reliable moving services for residential and commercial clients. As one of the top-rated movers on Google and Thumbtack, My Move Day is known for delivering efficient, affordable, and stress-free moving experiences. Whether you need local movers, long-distance movers, or full-service packing and moving solutions, My Move Day is committed to exceptional customer service and seamless relocations. moving company in fairfax va